Genetics and Biology of KID Syndrome
At a Glance
KID syndrome is usually caused by a new GJB2 variant affecting connexin 26, but it can be inherited. Testing can identify variants, distinguish rare AP1B1-related KIDAR, and clarify potential severity and recurrence risks for families.
To understand KID syndrome, it helps to think of the body as a vast network of communication. Your or your child’s cells need to “talk” to one another to function correctly. In KID syndrome, a small change in the genetic instructions disrupts this communication, leading to the symptoms you see in the skin, eyes, and ears [1][2].
The Role of Connexin 26 and GJB2
Most cases of classic KID syndrome are caused by a mutation in a gene called GJB2 [3]. This gene provides the instructions for making a protein called connexin 26.
Connexin 26 acts like a specialized building block for two types of cellular “doors”:
- Gap Junctions: These are direct tunnels between two neighboring cells. They allow small molecules to pass back and forth, keeping the tissue healthy [1].
- Hemichannels: These are doors that open to the space outside the cell. They help the cell respond to its environment [1][2].
In a simplified model of KID syndrome, the mutation often alters how these doors function. Instead of opening and closing precisely, they may stay open too long or fail to form the tunnels between cells properly [4][5]. This is particularly disruptive in the skin, the cornea (the front of the eye), and the inner ear, where connexin 26 is most active [2][6].
Common and Severe Genetic Variants
The most frequently reported mutation in KID syndrome is known as p.Asp50Asn (or D50N) [4]. While D50N causes the classic symptoms of the syndrome, its severity can vary significantly from one person to another, so genotype alone does not perfectly predict an individual’s course [7].
However, some specific mutations are known to be more severe:
- G45E and A88V: These variants are associated with severe or sometimes fatal outcomes in reported cases [8]. In small reported case series, infants with these specific mutations have faced much more significant challenges, including severe respiratory issues, poor weight gain, and life-threatening infections shortly after birth [8][6]. Identifying these variants early through genetic testing is crucial for helping doctors provide the most intensive level of care [8].
KIDAR: The Recessive Form
While classic KID syndrome usually occurs as a “de novo” (new) mutation, there is a very rare form called KIDAR (Keratitis-Ichthyosis-Deafness with Autosomal Recessive inheritance) [9].
KIDAR is caused by mutations in a different gene called AP1B1 [9]. While it shares the same triad of skin, eye, and ear issues, it often includes other symptoms that are not typically seen in classic KID, such as:
- Enteropathy: Severe digestive issues like chronic vomiting or diarrhea [9][10].
- Developmental Delays: Slower progress in reaching childhood milestones [9][11].
- Metabolic Changes: Abnormalities in how the body processes copper [9].
How the Condition is Inherited and Diagnosed
Genetic testing can confirm a clinical diagnosis, though a negative or uncertain result does not always rule out the condition. Molecular results should always be interpreted by a genetics professional.
- De Novo Mutations: Most children with classic KID syndrome are the first in their family to have it. The genetic change happened spontaneously during early development; it was not caused by anything the parents did [7][12]. When a child has a de novo mutation, the chance of parents having another child with the condition is low, but not zero (due to possible mosaicism).
- Autosomal Dominant: If a person has classic KID syndrome, they have a 50% chance of passing the gene to each child. This is called dominant inheritance because only one copy of the mutated gene is needed to cause the condition [7].
- Autosomal Recessive (KIDAR): In this form, both parents are typically healthy “carriers” of one mutated gene. A child only develops the condition if they inherit the mutated gene from both parents, creating a 25% recurrence risk per pregnancy [9].
Distinguishing Other Conditions
Sometimes KID syndrome can look like other genetic conditions, such as Clouston syndrome. While both can cause thickened skin on the palms and soles or hair loss, Clouston syndrome is caused by a different gene (GJB6) and usually does not cause the eye inflammation (keratitis) or hearing loss seen in KID [13][12]. Because these conditions can overlap, clinical evaluation and genetic testing help clarify the diagnosis [12][14].
Common questions in this guide
What gene is most often linked to classic KID syndrome?
Can KID syndrome be passed from a parent to a child?
What is KIDAR, and how is it different from classic KID syndrome?
What do D50N, G45E, and A88V mean on a KID genetic test?
Does genetic testing confirm KID syndrome?
What are the chances of KIDAR occurring again in a family?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About genetic testing
Would genetic testing help confirm my diagnosis?
How it is inherited
Could a genetics professional explain how KID syndrome is inherited?
What to expect
Could my genetic test results help clarify what to expect?
Get notified when new evidence is published on KID syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Calcium Regulation of Connexin Hemichannels.
Bayraktar E, Lopez-Pigozzi D, Bortolozzi M
International journal of molecular sciences 2024; (25(12)) doi:10.3390/ijms25126594.
PMID: 38928300 - 2
Assessing Hemichannel and Gap Junctional Channel Activities in HaCaT Keratinocyte Cells.
Inal E, Yildirim MA, Mese G
Methods in molecular biology (Clifton, N.J.) 2025; doi:10.1007/7651_2025_650.
PMID: 40613983 - 3
Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome.
Mc Lean K, Bignotti S, Callea M, et al.
Ophthalmic genetics 2024; (45(1)):16-22 doi:10.1080/13816810.2023.2258218.
PMID: 37755702 - 4
Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
Lee MY, Wang HZ, White TW, et al.
The Journal of investigative dermatology 2020; (140(5)):1035-1044.e7 doi:10.1016/j.jid.2019.09.022.
PMID: 31705875 - 5
Roles of aberrant hemichannel activities due to mutant connexin26 in the pathogenesis of KID syndrome.
Taki T, Takeichi T, Sugiura K, Akiyama M
Scientific reports 2018; (8(1)):12824 doi:10.1038/s41598-018-30757-3.
PMID: 30150638 - 6
Keratitis-ichthyosis-deafness syndrome with lethal p.Ala88Val variant and severe hypercalcemia.
López-Sundh AE, Escribano-Palomino E, Feito-Rodríguez M, et al.
American journal of medical genetics. Part A 2023; (191(1)):253-258 doi:10.1002/ajmg.a.63005.
PMID: 36286624 - 7
Keratitis-ichthyosis-deafness syndrome: Phenotypic heterogeneity and treatment perspective of patients with p.Asp50Asn GJB2 mutation.
Asgari T, Naji M, Mansouri P, et al.
Dermatologic therapy 2020; (33(6)):e14493 doi:10.1111/dth.14493.
PMID: 33136289 - 8
More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations.
Lilly E, Bunick CG, Maley AM, et al.
Journal of the American Academy of Dermatology 2019; (80(3)):617-625 doi:10.1016/j.jaad.2018.09.042.
PMID: 30287322 - 9
Clinical, biochemical and cell biological characterization of KIDAR syndrome associated with a novel AP1B1 variant.
Kaniganti T, Gean-Akriv G, Keidar T, et al.
Molecular genetics and metabolism 2025; (144(4)):109056 doi:10.1016/j.ymgme.2025.109056.
PMID: 40101690 - 10
Expanding the Clinical Spectrum of KIDAR Syndrome: A Case of Multisystemic Involvement in a Palestinian Child with AP1B1 Deficiency.
Issa K, Dawoud AMY, Khader ZWR, et al.
Sage open pediatrics 2026; (13()):30502225261436884 doi:10.1177/30502225261436884.
PMID: 41948131 - 11
Further delineation of KIDAR syndrome: Two new cases with novel variants, functional analysis of the variants and a comprehensive review.
Altıner Ş, Gökpınar İli E, Yurtdaş AK, et al.
Journal of human genetics 2026; (71(8)):513-520 doi:10.1038/s10038-026-01476-9.
PMID: 42032344 - 12
The Clinical Manifestation of p.Asp50Asn Heterozygous Mutation of GJB2 Gene in 3 Members of a Family Is Similar to That of Clouston Syndrome.
Xu Y, Wang M, Huang L, Hu J
Annals of dermatology 2022; (34(5)):382-386 doi:10.5021/ad.20.278.
PMID: 36198631 - 13
Phenotypic variability in gap junction syndromic skin disorders: experience from KID and Clouston syndromes' clinical diagnostics.
Kutkowska-Kaźmierczak A, Niepokój K, Wertheim-Tysarowska K, et al.
Journal of applied genetics 2015; (56(3)):329-37 doi:10.1007/s13353-014-0266-1.
PMID: 25575739 - 14
Parental mosaic cutaneous-gonadal GJB2 mutation: From epidermal nevus to inherited ichthyosis-deafness syndrome.
Cohen-Barak E, Mwassi B, Zagairy F, et al.
The Journal of dermatology 2022; (49(3)):379-382 doi:10.1111/1346-8138.16268.
PMID: 34889473
This page explains KID syndrome genetics for informational purposes only and does not constitute medical advice. A genetics professional should interpret test results and discuss your family’s recurrence risks and care.